Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas
Despite the widespread clinical use of dynamic susceptibility contrast (DSC) MRI, DSC-MRI methodology has not been standardized, hindering its utilization for response assessment in multicenter trials. Recently, the DSC-MRI Standardization Subcommittee of the Jumpstarting Brain Tumor Drug Developmen...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
09 June 2020
|
| In: |
Neuro-Oncology
Year: 2020, Jahrgang: 22, Heft: 9, Pages: 1262-1275 |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/noaa141 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/neuonc/noaa141
|
| Verfasserangaben: | Jerrold L Boxerman, Chad C Quarles, Leland S Hu, Bradley J Erickson, Elizabeth R Gerstner, Marion Smits, Timothy J Kaufmann, Daniel P Barboriak, Raymond H Huang, Wolfgang Wick, Michael Weller, Evanthia Galanis, Jayashree Kalpathy-Cramer, Lalitha Shankar, Paula Jacobs, Caroline Chung, Martin J van den Bent, Susan Chang, W K Al Yung, Timothy F Cloughesy, Patrick Y Wen, Mark R Gilbert, Bruce R Rosen, Benjamin M Ellingson, and Kathleen M Schmainda, and Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1750017873 | ||
| 003 | DE-627 | ||
| 005 | 20220819122633.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210301s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/neuonc/noaa141 |2 doi | |
| 035 | |a (DE-627)1750017873 | ||
| 035 | |a (DE-599)KXP1750017873 | ||
| 035 | |a (OCoLC)1341396522 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas |c Jerrold L Boxerman, Chad C Quarles, Leland S Hu, Bradley J Erickson, Elizabeth R Gerstner, Marion Smits, Timothy J Kaufmann, Daniel P Barboriak, Raymond H Huang, Wolfgang Wick, Michael Weller, Evanthia Galanis, Jayashree Kalpathy-Cramer, Lalitha Shankar, Paula Jacobs, Caroline Chung, Martin J van den Bent, Susan Chang, W K Al Yung, Timothy F Cloughesy, Patrick Y Wen, Mark R Gilbert, Bruce R Rosen, Benjamin M Ellingson, and Kathleen M Schmainda, and Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee |
| 264 | 1 | |c 09 June 2020 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 01.03.2021 | ||
| 520 | |a Despite the widespread clinical use of dynamic susceptibility contrast (DSC) MRI, DSC-MRI methodology has not been standardized, hindering its utilization for response assessment in multicenter trials. Recently, the DSC-MRI Standardization Subcommittee of the Jumpstarting Brain Tumor Drug Development Coalition issued an updated consensus DSC-MRI protocol compatible with the standardized brain tumor imaging protocol (BTIP) for high-grade gliomas that is increasingly used in the clinical setting and is the default MRI protocol for the National Clinical Trials Network. After reviewing the basis for controversy over DSC-MRI protocols, this paper provides evidence-based best practices for clinical DSC-MRI as determined by the Committee, including pulse sequence (gradient echo vs spin echo), BTIP-compliant contrast agent dosing (preload and bolus), flip angle (FA), echo time (TE), and post-processing leakage correction. In summary, full-dose preload, full-dose bolus dosing using intermediate (60°) FA and field strength-dependent TE (40-50 ms at 1.5 T, 20-35 ms at 3 T) provides overall best accuracy and precision for cerebral blood volume estimates. When single-dose contrast agent usage is desired, no-preload, full-dose bolus dosing using low FA (30°) and field strength-dependent TE provides excellent performance, with reduced contrast agent usage and elimination of potential systematic errors introduced by variations in preload dose and incubation time. | ||
| 700 | 1 | |a Boxerman, Jerrold L |e VerfasserIn |0 (DE-588)1228282196 |0 (DE-627)1750022656 |4 aut | |
| 700 | 1 | |a Quarles, Chad C |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hu, Leland S |e VerfasserIn |4 aut | |
| 700 | 1 | |a Erickson, Bradley J |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gerstner, Elizabeth R |e VerfasserIn |4 aut | |
| 700 | 1 | |a Smits, Marion |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kaufmann, Timothy J |e VerfasserIn |4 aut | |
| 700 | 1 | |a Barboriak, Daniel P |e VerfasserIn |4 aut | |
| 700 | 1 | |a Huang, Raymond H |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wick, Wolfgang |d 1970- |e VerfasserIn |0 (DE-588)120297736 |0 (DE-627)080586929 |0 (DE-576)186221320 |4 aut | |
| 700 | 1 | |a Weller, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Galanis, Evanthia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kalpathy-Cramer, Jayashree |e VerfasserIn |4 aut | |
| 700 | 1 | |a Shankar, Lalitha |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jacobs, Paula |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chung, Caroline |e VerfasserIn |4 aut | |
| 700 | 1 | |a van den Bent, Martin J |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chang, Susan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Al Yung, W K |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cloughesy, Timothy F |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wen, Patrick Y |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gilbert, Mark R |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rosen, Bruce R |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ellingson, Benjamin M |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmainda, Kathleen M |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neuro-Oncology |d Oxford : Oxford Univ. Press, 1999 |g 22(2020), 9, Seite 1262-1275 |h Online-Ressource |w (DE-627)357167341 |w (DE-600)2094060-9 |w (DE-576)318041839 |x 1523-5866 |7 nnas |a Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas |
| 773 | 1 | 8 | |g volume:22 |g year:2020 |g number:9 |g pages:1262-1275 |g extent:14 |a Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas |
| 856 | 4 | 0 | |u https://doi.org/10.1093/neuonc/noaa141 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210301 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 120297736 |a Wick, Wolfgang |m 120297736:Wick, Wolfgang |d 910000 |d 911100 |e 910000PW120297736 |e 911100PW120297736 |k 0/910000/ |k 1/910000/911100/ |p 10 | ||
| 999 | |a KXP-PPN1750017873 |e 3879606315 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Jerrold L Boxerman, Chad C Quarles, Leland S Hu, Bradley J Erickson, Elizabeth R Gerstner, Marion Smits, Timothy J Kaufmann, Daniel P Barboriak, Raymond H Huang, Wolfgang Wick, Michael Weller, Evanthia Galanis, Jayashree Kalpathy-Cramer, Lalitha Shankar, Paula Jacobs, Caroline Chung, Martin J van den Bent, Susan Chang, W K Al Yung, Timothy F Cloughesy, Patrick Y Wen, Mark R Gilbert, Bruce R Rosen, Benjamin M Ellingson, and Kathleen M Schmainda, and Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee"]},"id":{"doi":["10.1093/neuonc/noaa141"],"eki":["1750017873"]},"physDesc":[{"extent":"14 S."}],"recId":"1750017873","origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"09 June 2020"}],"relHost":[{"disp":"Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomasNeuro-Oncology","recId":"357167341","physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"22(2020), 9, Seite 1262-1275","extent":"14","issue":"9","pages":"1262-1275","volume":"22","year":"2020"},"title":[{"subtitle":"official journal of the World Federation of Neuro-Oncology","title_sort":"Neuro-Oncology","title":"Neuro-Oncology"}],"id":{"issn":["1523-5866"],"eki":["357167341"],"zdb":["2094060-9"]},"note":["Gesehen am 21.07.23"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"pubHistory":["1.1999 -"],"origin":[{"dateIssuedKey":"1999","publisherPlace":"Oxford ; Durham, NC","dateIssuedDisp":"1999-","publisher":"Oxford Univ. Press ; Duke University Medical Center"}]}],"person":[{"given":"Jerrold L","role":"aut","family":"Boxerman","display":"Boxerman, Jerrold L"},{"display":"Quarles, Chad C","role":"aut","given":"Chad C","family":"Quarles"},{"display":"Hu, Leland S","family":"Hu","role":"aut","given":"Leland S"},{"given":"Bradley J","role":"aut","family":"Erickson","display":"Erickson, Bradley J"},{"family":"Gerstner","given":"Elizabeth R","role":"aut","display":"Gerstner, Elizabeth R"},{"role":"aut","given":"Marion","family":"Smits","display":"Smits, Marion"},{"display":"Kaufmann, Timothy J","family":"Kaufmann","given":"Timothy J","role":"aut"},{"display":"Barboriak, Daniel P","role":"aut","given":"Daniel P","family":"Barboriak"},{"family":"Huang","given":"Raymond H","role":"aut","display":"Huang, Raymond H"},{"given":"Wolfgang","role":"aut","family":"Wick","display":"Wick, Wolfgang"},{"display":"Weller, Michael","given":"Michael","role":"aut","family":"Weller"},{"given":"Evanthia","role":"aut","family":"Galanis","display":"Galanis, Evanthia"},{"display":"Kalpathy-Cramer, Jayashree","role":"aut","given":"Jayashree","family":"Kalpathy-Cramer"},{"family":"Shankar","role":"aut","given":"Lalitha","display":"Shankar, Lalitha"},{"family":"Jacobs","role":"aut","given":"Paula","display":"Jacobs, Paula"},{"family":"Chung","role":"aut","given":"Caroline","display":"Chung, Caroline"},{"family":"van den Bent","given":"Martin J","role":"aut","display":"van den Bent, Martin J"},{"display":"Chang, Susan","family":"Chang","role":"aut","given":"Susan"},{"given":"W K","role":"aut","family":"Al Yung","display":"Al Yung, W K"},{"family":"Cloughesy","role":"aut","given":"Timothy F","display":"Cloughesy, Timothy F"},{"given":"Patrick Y","role":"aut","family":"Wen","display":"Wen, Patrick Y"},{"given":"Mark R","role":"aut","family":"Gilbert","display":"Gilbert, Mark R"},{"family":"Rosen","given":"Bruce R","role":"aut","display":"Rosen, Bruce R"},{"family":"Ellingson","role":"aut","given":"Benjamin M","display":"Ellingson, Benjamin M"},{"display":"Schmainda, Kathleen M","family":"Schmainda","role":"aut","given":"Kathleen M"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"note":["Gesehen am 01.03.2021"],"title":[{"title":"Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas","title_sort":"Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas"}]} | ||
| SRT | |a BOXERMANJECONSENSUSR0920 | ||